Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida
Screening considerations should include assessment of cardiovascular status given BPC-157's effects on blood pressure and vascular tone
Integrating BPC-157 into experimental protocols Most scientists believe they can integrate BPC-157 into experimental protocols
500 mcg 30 capsules $150 Released by the cells of the immune system, this peptide works against bacteria and other infectious agents as a front-line defender
US$ 23.10
US$ 29.49
US$ 22.83
US$ 24.14
US$ 25.73
US$ 28.51
US$ 29.34